Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Johan Neyts and Kai Dallmeier.
Johan Neyts
Connection Strength
1.842
Kai Dallmeier
  1. COVID-19 and the intensive care unit: vaccines to the rescue. Intensive Care Med. 2021 07; 47(7):786-789.
    View in: PubMed
    Score: 0.947
  2. Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters. EBioMedicine. 2021 Jun; 68:103403.
    View in: PubMed
    Score: 0.237
  3. A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate. Nature. 2021 02; 590(7845):320-325.
    View in: PubMed
    Score: 0.229
  4. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters. Nat Commun. 2020 11 17; 11(1):5838.
    View in: PubMed
    Score: 0.228
  5. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2. Nat Genet. 2021 04; 53(4):435-444.
    View in: PubMed
    Score: 0.058
  6. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. Proc Natl Acad Sci U S A. 2020 10 27; 117(43):26955-26965.
    View in: PubMed
    Score: 0.057
  7. Animal models for COVID-19. Nature. 2020 10; 586(7830):509-515.
    View in: PubMed
    Score: 0.057
  8. Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics. J Antimicrob Chemother. 2011 Jun; 66(6):1287-94.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.